Skip to content

Prefrontal cortex activation in perimenopausal women with different levels of cognition: a functional near-infrared spectroscopy study

Near-infrared functional brain imaging of the prefrontal cortex in perimenopausal women with different cognitive levels

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300069753
Enrollment
Unknown
Registered
2023-03-24
Start date
2023-04-01
Completion date
Unknown
Last updated
2023-05-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cognitive Impairment

Interventions

Sponsors

The People's Hospital of Bao'an, Shenzhen
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
40 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1. Perimenopausal women without cognitive impairment. (1) Meets diagnostic criteria for perimenopause. (2) Aged between of 40-60 years. (4) SCD-Q9 score <5. (5) MoCA score of =26; (1 point added to the score if =12 years of education) (6) Right-handedness. (7) Signed informed consent and voluntary participation. 2. SCD perimenopausal women. (1) Meets the diagnostic criteria for SCD. (2) Meets the criteria for perimenopausal diagnosis. (3) Aged between 40-60 years. (4) SCD-Q9 score = 5. (5) MoCA score of =26; (if years of education =12, add 1 point to the score) (6) Right-handedness. (7) Signed informed consent and voluntary participation. 3. MCI perimenopausal women. (1) Meeting the diagnostic criteria for MCI (2) Meeting the diagnostic criteria for perimenopause. (3) Ages between 40-60 years of age (4) MoCA score between 18-25; (1 point will be added to the score if the number of years of education is =12 years) (5) Right-handedness. (6) Signed informed consent form and voluntary participation.

Exclusion criteria

Exclusion criteria: (1) Have a history of psychiatric disorders. (2) have a history of neurological disorders (3) A history of alcohol or drug abuse (4) surgical menopause (history of hysterectomy and bilateral adnexal resection) (5) Reproductive tumours and vaginal bleeding of unknown origin. (6) Hormonal drugs taken in the last 3 months prior to study participation. (7) Those who are unable to complete the index assessment, such as severe aphasia, visual and hearing impairment, illiteracy, etc. (8) Those who are participating in other research trials that affect the results of this study. (9) Not signing informed consent.

Design outcomes

Primary

MeasureTime frame
Oxyhemoglobin concentration;

Secondary

MeasureTime frame
Subjective Perception Decline Questionnaire;MoCA;Digital span test;Menopause assessment;Depression Screening Scale;Anxiety Self-Assessment Scale;Sleep Quality Index;working memory;Activities of daily living;

Countries

China

Contacts

Public ContactChen Shangjie

The People's Hospital of Bao'an, Shenzhen

Csjme@163.com15899797851

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026